External link for DFJ Growth
DFJ Growth reposted this
Happy to see Randy Glein and Barry Schuler on the 2024 Forbes Midas List - a first for DFJ Growth to have two partners recognized in the same year. Their leadership, commitment, passion, and joy in supporting startups is evident every single day. https://lnkd.in/gEH9Fhxg https://lnkd.in/gH-kZXbp https://lnkd.in/gkuYZqd5
Congratulations to DFJ Growth Partners Randy Glein and Barry Schuler on the 2024 Midas List, Forbes’ ranking of the world’s top venture capitalists! Randy: https://lnkd.in/gS5sYYU5 Barry: https://lnkd.in/gC93tHaf Read less
We are thrilled to announce our investment in Scale AI’s $1 billion Series F financing as part of our expanding thesis and growing portfolio in the generative AI movement. https://lnkd.in/gAq2J2_T
Founder Story: Victor Velculescu on starting DELFI Diagnostics and devoting his career to the fight against cancer https://lnkd.in/gbM6-cud
Want to learn why transparency in support is good for business? Then join @Mathilde Collin (@Front) and @Parker Conrad (@Rippling) as they share: ✅ Why they took the risk to make their support metrics public, and what the ROI has been ✅ How to maintain support stats that far exceed industry benchmarks, and what to do if your metrics start to slip ✅ Why support should be a top priority for any CEO Save your seat for Feb 8: https://lnkd.in/e9dPVuD8
Rippling made waves when they went public with the real-time support metrics, and the following year Front did the same. Now CEOs Parker Conrad and Mathilde Collin will host a conversation to share: 📈The ROI of making your support metrics public 🚀How to maintain support stats that far exceed industry benchmarks…and why you can’t hide behind rosy averages 👪 Why *everyone*, from leaders to engineers, should directly engage with customers Join us on February 8 at 11am PT for the second installment of our Customer Service Game Changers series: Why Making Your Support Metrics Public Is Worth the Risk https://bit.ly/4aX9mVT
Cellares is on a mission to meet the total patient demand for cell therapies globally. Fabian Gerlinghaus and Omar Kurdi share their founder story. https://lnkd.in/diPRVk_q